Acute pancreatitis (AP) is an established complication in ALL treatment, associated with the use of asparaginase.[10] In Chen study, 4.00% (n = 353) of patients developed AAP (asparaginase-associated pancreatitis). This evidence concerns the gene ASPG and pancreatitis.